Diabetic Nephropathy
4 competing products in clinical development for Diabetic Nephropathy.
Pipeline by Phase
Pre-clinical1
Phase 21
Phase 31
Approved1
All Products (4)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Anplag(Sarpogrelate) + Placebo | Yuhan | Approved | Completed | 43 |
| olmesartan medoxomil + Placebo Tablets | Daiichi Sankyo | Phase 3 | Completed | 40 |
| CS-3150 + placebo | Daiichi Sankyo | Phase 2 | Completed | 35 |
| Beraprost sodium | Astellas Pharma | Pre-clinical | UNKNOWN | 22 |